Government-Sourced · H-1B DOL Filings

Sarepta Therapeutics, Inc.

Senior Engineer, Gene Therapy Upstream Process Development Salary

Based on 4 verified H-1B filings from the US Department of Labor.

$105,812
Average / Year
$104,416
Median / Year
$110,000
Maximum
$104,416
Minimum
Per Hour$51
Per Month$8,818
vs National Avg+$22,912
H-1B Filings4

For informational purposes only. Derived from H-1B LCA disclosures filed with the US Department of Labor. May not represent all employees. See Terms →

Senior Engineer, Gene Therapy Upstream Process Development — Top Paying Companies

Compare across employers

Other Roles at Sarepta Therapeutics, Inc.

More salary data from this employer

Frequently Asked Questions

Common questions about Sarepta Therapeutics, Inc. salaries

How much does Sarepta Therapeutics, Inc. pay Senior Engineer, Gene Therapy Upstream Process Developments?
Sarepta Therapeutics, Inc. pays an average of $105,812 per year for Senior Engineer, Gene Therapy Upstream Process Development roles based on 4 verified H-1B government filings. Salaries range from $104,416 to $110,000 depending on experience and location.
How much does Sarepta Therapeutics, Inc. pay per hour for Senior Engineer, Gene Therapy Upstream Process Development?
Based on the average annual salary of $105,812, a Senior Engineer, Gene Therapy Upstream Process Development at Sarepta Therapeutics, Inc. earns approximately $51 per hour assuming a standard 40-hour work week (2,080 working hours per year).
Is Sarepta Therapeutics, Inc. Senior Engineer, Gene Therapy Upstream Process Development salary above the national average?
Sarepta Therapeutics, Inc. pays $22,912 above the national average for similar roles. Sarepta Therapeutics, Inc. is among the higher paying employers for this role.
How accurate is this Sarepta Therapeutics, Inc. salary data?
This data is sourced from H-1B Labor Condition Application (LCA) disclosures filed publicly with the US Department of Labor — legally binding government filings. They may not represent employees hired domestically without H-1B sponsorship.